Levy C, Trivedi PJ, Kowdley KV, Gordon SC, et al. Long-term Efficacy and Safety of Selective PPARdelta Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results. Am J Gastroenterol 2025 Jun 24. doi: 10.14309/ajg.0000000000003603.
PMID: 40553148